The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

VIVUS Inc

Nasdaq: VVUS(*D)
Last

(U.S.) $0.67

Today's change-0.01 -0.90%
Updated November 17 4:00 PM EST. Delayed by at least 15 minutes.
 

VIVUS Inc

Nasdaq: VVUS(*D)
Last

(U.S.) $0.67

Today's change-0.01 -0.90%
Updated November 17 4:00 PM EST. Delayed by at least 15 minutes.

VIVUS Inc down (U.S.)$0.01

VIVUS Inc closed lower Friday, dropping (U.S.)$0.01 or 0.90% to (U.S.)$0.67. Over the last five days, shares have gained 5.00%, but are down 41.57% for the last year to date. Shares have underperformed the S&P 500 by 60.48% during the last year.

Key company metrics

  • Open(U.S.) $0.67
  • Previous close(U.S.) $0.68
  • High(U.S.) $0.71
  • Low(U.S.) $0.67
  • Bid / Ask(U.S.) $0.67 / (U.S.) $1.09
  • YTD % change-41.57%
  • Volume400,551
  • Average volume (10-day)591,406
  • Average volume (1-month)798,956
  • Average volume (3-month)789,379
  • 52-week range(U.S.) $0.61 to (U.S.) $1.47
  • Beta0.78
  • Trailing P/E2.01×
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.33
Updated November 17 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+26.71%

Based on its net profit margin of 26.71%, VIVUS Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.40%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201709/30/2017Jun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016
Revenue15112782
Total other revenue--------
Total revenue15112782
Gross profit1282180
Total cost of revenue4462
Total operating expense13162017
Selling / general / administrative8121113
Research & development1122
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)------0
Other operating expenses, total--------
Operating income2-5765
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-6-13-157
Income after tax-6-13-157
Income tax, total0000
Net income-6-13-157
Total adjustments to net income--------
Net income before extra. items-6-13-157
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-6-13-157
Inc. avail. to common incl. extra. items-6-13-157
Diluted net income-6-13-157
Dilution adjustment--0--0
Diluted weighted average shares106106105107
Diluted EPS excluding extraordinary itemsvalue per share-0.06-0.13-0.010.53
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share-0.06-0.13-0.010.53